BIO2d
New survey: U.S. biotechs warn tariffs could impede access to cures, stifle innovation
WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...
BIO4d
BIO Releases New Report Underscoring the Massive Economic Power of the American Bioeconomy
WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the ...
BIO4d
Report: Bioeconomy’s potential is huge, but it needs support
A new report released by BIO highlights the potential of the bioeconomy – if we give it support. Plus, more news on federal funding for bird flu interventions, the need to invest in women's health, ...
BIO11d
Patient advocates urge PPRV renewal
Patient advocates explain why the Pediatric Priority Review Voucher (PPRV) Program must be reauthorized, and National Ag Day highlights the links between biotech and agriculture. (982 words, 4 minutes ...
BIO1mon
BIO Applauds Introduction of Bipartisan Bill to Eliminate the Pill Penalty
WASHINGTON D.C. (February 25, 2025) – John Crowley, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after Representatives Gregory Murphy (R-NC), ...
BIO1mon
Rare Disease Day: BIO urges legislative and regulatory reforms
We’re getting ready for Rare Disease Day (February 28) with a look at how policy can support patients and how BIO is engaging with the FDA. (960 words, 4 minutes, 48 seconds) Ahead of Rare Disease Day ...
BIO25d
A 'pill penalty' fix and bipartisan calls for PBM reform
A busy week in Washington, D.C., brought legislation to fix the Inflation Reduction Act “pill penalty,” bipartisan calls for PBM reform, and BIO CEO John F. Crowley explaining why Congress needs to ...
BIO18d
Plea to Congress on PPRV; women's health
BIO President & CEO John F. Crowley writes Congress to urge PPRV passage; plus a deep dive into the impact of autoimmune disease on women. (761 words, 3 minutes, 48 seconds) “It is critical to pass ...
BIO8mon
CSBA Resources and Reports
The U.S. Bioscience Economy: Driving Economic Growth and Opportunity in States and Regions ...
BIO2y
BIO Business Solutions
Browse the cost savings options for your organization: ...
BIO1y
What is Biotechnology?
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...
BIO4y
About BIO
BIO is the world’s largest advocacy association representing biotechnology companies, academic and research institutions, state biotechnology centers and related organizations across the United States ...